China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An Observational Study on the Efficacy and Safety of Aparolidorelimab in the Treatment of Advanced Solid Tumors'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133898
Registration Time: 2026/10/09
Type: Observational study
Primary Sponsor: Huai He Hospital of Henan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=329587
Published by HT Digital Content Services with permission from Health Daily Digest....